Skip to main content
Advertisement
Advertisement

ERNA

ERNA logo

Ernexa Therapeutics Inc. Common Stock

3.62
USD
Sponsored
-0.03
-0.82%
Sep 24, 15:59 UTC -4
Closed
exchange

Pre-Market

3.79

+0.17
+4.70%

ERNA Earnings Reports

Positive Surprise Ratio

ERNA beat 11 of 19 last estimates.

58%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$3.91
Implied change from Q2 26 (Revenue/ EPS)
--
/
+15.00%
Implied change from Q3 25 (Revenue/ EPS)
--
/
--

Ernexa Therapeutics Inc. Common Stock earnings per share and revenue

On Aug 06, 2026, ERNA reported earnings of -3.40 USD per share (EPS) for Q2 26, missing the estimate of -3.36 USD, resulting in a -1.01% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.44% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -3.91 USD, with revenue projected to reach -- USD, implying an increase of 15.00% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Ernexa Therapeutics Inc. Common Stock reported EPS of -$3.40, missing estimates by -1.01%, and revenue of --, -- -- expectations.
The stock price moved down -3.44%, changed from $4.36 before the earnings release to $4.21 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on -- analysts, Ernexa Therapeutics Inc. Common Stock is expected to report EPS of -$3.91 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement